Hyperphosphatemia in CKD contributes to bone disease through which mechanism?

• A. Hypophosphatemia causing osteomalacia.
• B. Hyperphosphatemia with secondary hyperparathyroidism causing bone disease.
• C. Direct phosphate nephrotoxicity causing bone loss.
• D. Calcium overload causing adynamic bone disease.

Answer: (B)

Hyperphosphatemia in CKD contributes to bone disease primarily through stimulation of secondary hyperparathyroidism. When phosphate accumulates because the diseased kidneys can’t excrete it effectively, it disrupts calcium balance and, with reduced calcitriol production, lowers serum calcium. The fall in calcium and vitamin D activity triggers the parathyroid glands to release more PTH. Elevated PTH drives increased bone turnover and resorption in an attempt to restore calcium levels, leading to renal osteodystrophy. This mechanism—phosphate-driven secondary hyperparathyroidism causing high-turnover bone disease—is the key link between CKD-associated hyperphosphatemia and bone pathology. The other options don’t fit the typical CKD bone disease pattern: hypophosphatemia isn’t the issue here, direct phosphate toxicity to bone isn’t the main mechanism, and calcium overload leading to adynamic bone disease describes a different, low-turnover scenario.